Gambia vs Mus: Previously treated cases tested for RR-/MDR-TB (%)
Gambia
100.0%
in 2024
Mus
100.0%
in 2022
Gambia rank
1st
Mus rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Gambia
- Mus
How they compare
Gambia currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
Across all 14 years both countries report, Mus has been ahead every year.
Gambia ranks 1st and Mus ranks 1st of 180 countries.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.8% | 100.0% | 47.2% | Mus |
| 2010s | 53.6% | 100.0% | 46.4% | Mus |
| 2020s | 82.3% | 100.0% | 17.7% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Mus?
- Gambia, at 100.0% against 100.0% in Mus as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Mus?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Mus?
- 14 years are reported by both, from 2006 to 2022.
- How do Gambia and Mus rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Mus ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.